Cargando…
Pathologic Predictors of Response to Treatment of Immune Checkpoint Inhibitor–Induced Kidney Injury
SIMPLE SUMMARY: Immune related adverse events (irAEs) are a management challenge with an associated increased morbidity and mortality. The most common renal toxicity is acute interstitial nephritis (AIN), which may be analogous to kidney transplant rejection. In a retrospective cohort of 35 patients...
Autores principales: | Abudayyeh, Ala, Suo, Liye, Lin, Heather, Mamlouk, Omar, Abdel-Wahab, Noha, Tchakarov, Amanda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9656112/ https://www.ncbi.nlm.nih.gov/pubmed/36358686 http://dx.doi.org/10.3390/cancers14215267 |
Ejemplares similares
-
Checkpoint inhibitor-related renal vasculitis and use of rituximab
por: Mamlouk, Omar, et al.
Publicado: (2020) -
Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
por: Abdelrahim, Maen, et al.
Publicado: (2021) -
Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience
por: Mamlouk, Omar, et al.
Publicado: (2019) -
Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis
por: Lin, Jamie S., et al.
Publicado: (2021) -
Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
por: Lin, Jamie S, et al.
Publicado: (2020)